Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - GROSS PROFIT
Gross Profit UTHR - United Therapeutics Corporation
2.07 B
LAST VALUE
15.08%
2 YEAR CAGR
7.69%
5 YEAR CAGR
7.70%
10 YEAR CAGR